At a glance
- Originator Henning Berlin
- Class Anti-inflammatories; Benzaldehydes; Hydrazones; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Crohn's disease; Ulcerative colitis
Most Recent Events
- 29 May 2000 Discontinued-Preclinical for Crohn's disease in Germany (PO)
- 29 May 2000 Discontinued-Preclinical for Ulcerative colitis in Germany (PO)
- 03 Nov 1998 No-Development-Reported for Crohn's disease in Germany (PO)